Please ensure Javascript is enabled for purposes of website accessibility

3 Stocks Immune to the Coronavirus

By Rick Munarriz – Updated Jun 25, 2020 at 3:24PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The same stocks that have been thriving in the new normal will continue to raise the bar until the pandemic is contained.

We're not getting any closer to cracking the COVID-19 code, and that's going to understandably make you nervous as an investor but even more so as a human being. This is a scary pandemic. However, it's undeniable that some companies are flourishing in the new normal.

Livongo Health (LVGO), Peloton (PTON -4.18%), and Teladoc (TDOC -3.46%) are three of 2020's hottest stocks, soaring through the outbreak with year-to-date gains of 195%, 96%, and 135%, respectively, as of Wednesday's close. It's a fair bet that they will continue to thrive as the coronavirus crisis plays out.

A green stock chart arrow moving higher than a red arrow.

Image source: Getty Images.


There are 34.2 million people with diabetes in the U.S. -- that's more than 10% of the country -- and another third of the population have prediabetes. 

We know that folks with diabetes can help their outcomes through exercise and embracing healthier lifestyles, but having someone perpetually keeping tabs on the situation and proactively nudging you in the right direction wasn't feasible until Livongo Health pioneered what it calls advanced health signals. Using connected glucose meters, data scientists and machine learning provide active coaching with every pin prick. Instead of relying on in-office medical guidance, which could be months away, Livongo knows when to step up and nudge a member in the right direction when blood sugar levels start to climb. 

Livongo's platform works. The insurance plans and self-insured companies offering Livongo are seeing an average annual savings of $1,908 in reduced medical costs per member, and glucose levels are dramatically improving within just a couple of months on the platform. Not surprisingly, Livongo's user base doubled to 328,000 members in the first quarter. Now the company is trying to catch lightning in a bottle again by using applied health signals to control other chronic conditions such as hypertension and depression, and in weight management.


Shares of Peloton hit another all-time high on Wednesday, and it's easy to see why the market's breaking a sweat for the company behind the high-end at-home workouts. Crowded spinning classes and sweaty gyms aren't safe these days, and Peloton allows folks with deep pockets to spend four figures on a stationary bike or treadmill that is connected wirelessly to interactive workouts that stream on attached monitors.

Peloton's connected-fitness subscriber count has soared 94% to 886,100 over the past year. Churn is at a four-year low, and growth has accelerated in the new normal. Peloton's revenue rose a hearty 66% in the first quarter, but its guidance for the quarter that ends next week calls for a 128% top-line surge at the midpoint. 


It's not just Livongo raising the bar when it comes to healthcare. Teladoc is championing telemedicine, using its growing network of medical professionals that can provide health consultations through videoconferencing. There are natural limitations to online consultations, but with gadgetry tech evolving and Teladoc's breadth of categories expanding, it's easy to see why folks are excited about the ability to seamlessly visit a health professional without having to deal with crowded waiting rooms and carving out hours of time for a process that ultimately just takes minutes.

Following in the footsteps of Livongo and Peloton, Teladoc is seeing its fan base widen dramatically these days. The 8 million to 9 million telehealth visits that Teladoc expects to complete this year is roughly double the 4.1 million sessions it completed in 2019. 

Livongo, Peloton, and Teladoc are exploding in popularity through the COVID-19 crisis. They are among the market's best growth stocks right now, proving that they are immune to the pandemic and thus may merit joining your portfolio.

Rick Munarriz owns shares of Livongo Health Inc, Peloton Interactive, and Teladoc Health. The Motley Fool owns shares of and recommends Livongo Health Inc, Peloton Interactive, and Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
$27.03 (-3.46%) $0.97
Livongo Health Inc Stock Quote
Livongo Health Inc
Peloton Interactive Stock Quote
Peloton Interactive
$8.49 (-4.18%) $0.37

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.